Pulmonary Drug Delivery Devices/Systems Market Analysis by Product (MDIs, DPIs, Nebulizers, Accessories), by Application, by Distribution Channel, by End-use and Segment Forecasts, 2014 - 2025

  • ID: 4396488
  • Report
  • 135 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • 3M Healthcare
  • AstraZeneca
  • Boehringer Ingelheim GmbH
  • GF Health Products, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • MORE
The global pulmonary drug delivery devices/systems market is expected to reach USD 55.1 billion by 2025., Increasing prevalence of chronic respiratory diseases is expected to boost the adoption of Pulmonary Drug Delivery Systems (PDDS). As per WHO, 235 million people suffer from asthma globally. Majority of the asthma related deaths occur in middle- to low-income countries due to lack of treatment options. This shows the potential demand for pulmonary drug delivery systems in the coming years.

Technological advancements in the field of drug delivery are expected to positively impact the pulmonary drug delivery devices market. These advancements include incorporation of agglomerated vesicle technology, MDI electronic dose counter, particle engineering, and supercritical fluid technology. Rising demand for new products, changing lifestyle, ease of use, and better facilities are factors expected to provide lucrative opportunities.

Furthermore, rise in number of public and private organizations is another major factor propelling the growth of pulmonary drug delivery devices market. For instance, organizations such as the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) are engaged in providing information in clinical and basic research on allergy, asthma, and clinical immunology. Such initiatives are in turn expected to increase the market demand for respiratory drug delivery devices in developing regions, thereby boosting overall market growth.

Further Key Findings From The Study Suggest:
  • Metered dose inhaler segment held the dominant share owing to its low cost and high adoption rate due to early introduction in the market
  • Chronic Obstructive Pulmonary Diseases (COPD) segment is anticipated to grow at a lucrative CAGR due to the presence of favorable reimbursement policies for treatment of COPD
  • High number of patients affected by asthma in developing and developed regions is likely to support the development of asthma applications for respiratory drug delivery devices
  • E-commerce segment is expected to witness lucrative growth. Development of this segment is supported by its associated benefits such as convenience, discounts, and flexibility
  • Home care segment is expected to exhibit exponential growth due to the introduction of technologically advanced, portable, and small-sized devices that can be used at home
  • Asia Pacific region is anticipated to grow at a lucrative CAGR. High prevalence of COPD, indicating a substantial socioeconomic burden in this region drives the growth in Asia Pacific
  • The market is progressing due to the rising demand for better treatment options, efficient drug delivery, and rapid treatment of local respiratory disorders


PLEASE NOTE:
This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M Healthcare
  • AstraZeneca
  • Boehringer Ingelheim GmbH
  • GF Health Products, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • MORE
Chapter 1 Research Methodology
1.1 Region Wise Market Calculation
1.1.1 Region wise market: Base estimates
1.1.2 Global market: CAGR calculation
1.2 Research Scope & Assumptions
1.3 List of Data Sources

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Pulmonary Drug Delivery Systems Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Increasing incidence of respiratory diseases
3.2.2 Technological advancements
3.2.3 Increasing initiatives from public and private organizations
3.3 Market Restraint Analysis
3.3.1 Regulatory issues and patent expiry of blockbuster drugs
3.4 Penetration & Growth Prospect Mapping
3.5 Pulmonary Drug Delivery Systems - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter’s
3.7 Company Market Share, 2016

Chapter 4 Pulmonary Drug Delivery Systems Market: Product Estimates & Trend Analysis
4.1 Pulmonary Drug Delivery Systems Market: Product Movement Analysis
4.2 Metered Dose Inhalers (MDIs)
4.2.1 Metered dose inhalers (MDIs) market, 2014 - 2025 (USD Million)
4.3 Dry Powder Inhalers (DPIs)
4.3.1 Dry powder inhalers (DPIs)market, 2014 - 2025 (USD Million)
4.4 Nebulizers
4.4.1 Nebulizers market, 2014 - 2025 (USD Million)
4.4.2 Mesh nebulizers
4.4.2.1 Mesh nebulizers market, 2014 - 2025 (USD Million)
4.4.2.2 Vibrating mesh nebulizers
4.4.2.2.1 Vibrating mesh nebulizers market, 2014 - 2025 (USD Million)
4.4.2.3 Static mesh nebulizers
4.4.2.3.1 Static mesh nebulizers market, 2014 - 2025 (USD Million)
4.4.3 Pneumatic nebulizers
4.4.3.1 Pneumatic nebulizers market, 2014 - 2025 (USD Million)
4.4.3.2 Vented pneumatic nebulizers
4.4.3.2.1 Vented pneumatic nebulizers market, 2014 - 2025 (USD Million)
4.4.3.3 Breath actuated pneumatic nebulizers
4.4.3.3.1 Breath actuated pneumatic nebulizers market, 2014 - 2025 (USD Million)
4.4.4 Ultrasonic nebulizers
4.4.4.1 Ultrasonic nebulizers market, 2014 - 2025 (USD Million)
4.5 Accessories
4.5.1 Accessories market, 2014 - 2025 (USD Million)

Chapter 5 Pulmonary Drug Delivery Systems Market: Application Estimates & Trend Analysis
5.1 Pulmonary Drug Delivery Systems Market: Application Movement Analysis
5.2 Asthma
5.2.1 Asthma market, 2014 - 2025 (USD Million)
5.3 Cystic Fibrosis
5.3.1 Cystic fibrosis market, 2014 - 2025 (USD Million)
5.4 Chronic Obstructive Pulmonary Disease
5.4.1 Chronic obstructive pulmonary disease market, 2014 - 2025 (USD Million)
5.5 Allergic Rhinitis
5.5.1 Allergic rhinitis market, 2014 - 2025 (USD Million)
5.6 Others
5.6.1 Others market, 2014 - 2025 (USD Million)

Chapter 6 Pulmonary Drug Delivery Systems Market: Distribution Channel Estimates & Trend Analysis
6.1 Pulmonary Drug Delivery Systems Market: Distribution Channel Movement Analysis
6.2 Retail Pharmacies
6.2.1 Retail pharmacies market, 2014 - 2025 (USD Million)
6.3 Hospital Pharmacies
6.3.1 Hospital pharmacies market, 2014 - 2025 (USD Million)
6.4 E-Commerce
6.4.1 E-commercemarket, 2014 - 2025 (USD Million)

Chapter 7 Pulmonary Drug Delivery Systems Market: End Use Estimates & Trend Analysis
7.1 Pulmonary Drug Delivery Systems Market: End Use Movement Analysis
7.2 Hospitals & Clinics
7.2.1 Hospitals & clinics market, 2014 - 2025 (USD Million)
7.3 Homecare
7.3.1 Homecare market, 2014 - 2025 (USD Million)

Chapter 8 Pulmonary Drug Delivery Systems Market: Regional Estimates & Trend Analysis, by Product, Application, Distribution Channel, and End Use
8.1 Pulmonary Drug Delivery Systems Market Share by Region, 2016& 2025
8.2 North America
8.2.1 North America pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
8.2.2 North America pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.2.3 North America pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.2.4 North America pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.2.5 North America pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
8.2.6 U.S.
8.2.6.1 U.S. pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.2.6.2 U.S. pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.2.6.3 U.S. pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.2.6.4 U.S. pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
8.2.7 Canada
8.2.7.1 Canada pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.2.7.2 Canada pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.2.7.3 Canada pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.2.7.4 Canada pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
8.3 Europe
8.3.1 Europe pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
8.3.2 Europe pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.3.3 Europe pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.3.4 Europe pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.3.5 Europe pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
8.3.6 UK
8.3.6.1 UK pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.3.6.2 UK pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.3.6.3 UK pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.3.6.4 UK pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
8.3.7 Germany
8.3.7.1 Germany pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.3.7.2 Germany pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.3.7.3 Germany pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.3.7.4 Germany pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
8.4.2 Asia Pacific pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.4.3 Asia Pacific pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.4.4 Asia Pacific pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.4.5 Asia Pacific pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
8.4.6 Japan
8.4.6.1 Japan pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.4.6.2 Japan pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.4.6.3 Japan pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.4.6.4 Japan pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
8.4.7 China
8.4.7.1 China pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.4.7.2 China pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.4.7.3 China pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.4.7.4 China pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
8.4.8 India
8.4.8.1 India pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.4.8.2 India pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.4.8.3 India pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.4.8.4 India pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
8.5 Latin America
8.5.1 Latin America pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
8.5.2 Latin America pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.5.3 Latin America pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.5.4 Latin America pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.5.5 Latin America pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
8.5.6 Brazil
8.5.6.1 Brazil pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.5.6.2 Brazil pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.5.6.3 Brazil pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.5.6.4 Brazil pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
8.5.7 Mexico
8.5.7.1 Mexico pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.5.7.2 Mexico pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.5.7.3 Mexico pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.5.7.4 Mexico pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
8.6 MEA
8.6.1 MEA pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
8.6.2 MEA pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.6.3 MEA pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.6.4 MEA pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.6.5 MEA pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
8.6.6 South Africa
8.6.6.1 South Africa pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
8.6.6.2 South Africa pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
8.6.6.3 South Africa pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
8.6.6.4 South Africa pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)

Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation
9.3 Company Profiles
9.3.1 GlaxoSmithKline plc
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Geographic foothold
9.3.1.4 Product benchmarking
9.3.1.5 Strategic initiatives
9.3.2 Philips Respironics
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Geographic foothold
9.3.2.4 Product benchmarking
9.3.2.5 Strategic initiatives
9.3.3 Boehringer Ingelheim GmbH
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Geographic foothold
9.3.3.4 Product benchmarking
9.3.3.5 Strategic initiatives
9.3.4 Novartis AG
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Geographic foothold
9.3.4.4 Product benchmarking
9.3.4.5 Strategic initiatives
9.3.5 3M Healthcare
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 GF Health Products, Inc.
9.3.6.1 Company overview
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.7 Merck & Co., Inc.
9.3.7.1 Company overview
9.3.7.2 Financial performance
9.3.7.3 Geographic foothold
9.3.7.4 Product benchmarking
9.3.8 AstraZeneca
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Geographic foothold
9.3.8.4 Product benchmarking
9.3.8.5 Strategic initiatives

List of Tables
Table 1 Country share estimation
Table 2 North America pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
Table 3 North America pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 4 North America pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 5 North America pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 6 North America pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
Table 7 U.S. pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 8 U.S. pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 9 U.S. pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 10 U.S. pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
Table 11 Canada pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 12 Canada pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 13 Canada pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 14 Canada pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
Table 15 Europe pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
Table 16 Europe pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 17 Europe pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 18 Europe pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 19 Europe pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
Table 20 UK pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 21 UK pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 22 UK pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 23 UK pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
Table 24 Germany pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 25 Germany pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 26 Germany pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 27 Germany pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
Table 28 Asia Pacific pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
Table 29 Asia Pacific pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 30 Asia Pacific pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 31 Asia Pacific pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 32 Asia Pacific pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
Table 33 Japan pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 34 Japan pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 35 Japan pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 36 Japan pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
Table 37 China pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 38 China pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 39 China pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 40 China pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
Table 41 India pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 42 India pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 43 India pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 44 India pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
Table 45 Latin America pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
Table 46 Latin America pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 47 Latin America pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 48 Latin America pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 49 Latin America pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
Table 50 Brazil pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 51 Brazil pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 52 Brazil pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 53 Brazil pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
Table 54 Mexico pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 55 Mexico pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 56 Mexico pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 57 Mexico pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
Table 58 MEA pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
Table 59 MEA pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 60 MEA pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 61 MEA pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 62 MEA pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
Table 63 South Africa pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
Table 64 South Africa pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
Table 65 South Africa pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
Table 66 South Africa pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)

List of Figures
FIG. 1 Market summary
FIG. 2 Market trends &outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 Pulmonary drug delivery systems market: Company share analysis, 2016
FIG. 10 Pulmonary drug delivery systems market, product outlook: Key takeaways
FIG. 11 Pulmonary drug delivery systems market: Product movement analysis
FIG. 12 Metered dose inhalers (MDIs) market, 2014 - 2025 (USD Million)
FIG. 13 Dry powder inhalers (DPIs) market, 2014 - 2025 (USD Million)
FIG. 14 Nebulizers market, 2014 - 2025 (USD Million)
FIG. 15 Mesh nebulizers market, 2014 - 2025 (USD Million)
FIG. 16 Vibrating mesh nebulizers market, 2014 - 2025 (USD Million)
FIG. 17 Static mesh nebulizers market, 2014 - 2025 (USD Million)
FIG. 18 Pneumatic nebulizers market, 2014 - 2025 (USD Million)
FIG. 19 Vented pneumatic nebulizers market, 2014 - 2025 (USD Million)
FIG. 20 Breath actuated pneumatic nebulizers market, 2014 - 2025 (USD Million)
FIG. 21 Ultrasonic nebulizers market, 2014 - 2025 (USD Million)
FIG. 22 Accessories market, 2014 - 2025 (USD Million)
FIG. 23 Pulmonary drug delivery systems market, application outlook: Key takeaways
FIG. 24 Pulmonary drug delivery systems market: Application movement analysis
FIG. 25 Asthma market, 2014 - 2025 (USD Million)
FIG. 26 Cystic fibrosis market, 2014 - 2025 (USD Million)
FIG. 27 Chronic obstructive pulmonary disease market, 2014 - 2025 (USD Million)
FIG. 28 Allergic rhinitis market, 2014 - 2025 (USD Million)
FIG. 29 Others market, 2014 - 2025 (USD Million)
FIG. 30 Pulmonary drug delivery systems market, distribution channel outlook: Key takeaways
FIG. 31 Pulmonary drug delivery systems market: distribution channel movement analysis
FIG. 32 Retail pharmacies market, 2014 - 2025 (USD Million)
FIG. 33 Hospital pharmacies market, 2014 - 2025 (USD Million)
FIG. 34 E-commerce market, 2014 - 2025 (USD Million)
FIG. 35 Pulmonary drug delivery systems market, end use outlook: Key takeaways
FIG. 36 Pulmonary drug delivery systems market: End use movement analysis
FIG. 37 Hospitals & clinics market, 2014 - 2025 (USD Million)
FIG. 38 Homecare market, 2014 - 2025 (USD Million)
FIG. 39 Regional market place: Key takeaways
FIG. 40 Regional outlook, 2016 & 2025
FIG. 41 Strategy framework
FIG. 42 Market participation and categorization
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • GlaxoSmithKline plc
  • Philips Respironics.
  • Boehringer Ingelheim GmbH
  • Novartis AG
  • 3M Healthcare
  • GF Health Products, Inc.
  • Merck & Co., Inc.
  • AstraZeneca
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll